whitepaper
Application note: Purification of nanoparticles by Hollow Fibre Diafiltration
Hollow Fibre Diafiltration is rapid alternative to traditional methods of nanoparticle purification like ultracentrifugation.
List view / Grid view
Drug delivery
whitepaper
Application Note: Multiparameter profiling of a Structure Activity Relationship (SAR) library for immunological activity in human PBMCs
We describe a no-wash, high throughput screen that provides a multiparametric activity profile for a structure activity relationship (SAR) library derived from immunomodulatory compounds...
news
Accelerate development of Cancer Immunotherapy (iOnc) drugs with new PathHunter® Checkpoint Assays from DiscoveRx
14 January 2016 | By DiscoveRx
DiscoveRx Corporation announced the expansion of its PathHunter cell-based assays portfolio with the release of PathHunter Checkpoint Assays...
news
Early immune effect of SCIB1 observed by ImmunTraCkeR diagnostic
11 January 2016 | By Victoria White
Cancer vaccine SCIB1 is a DNA ImmunoBody immunotherapy encoding a human IgG1 antibody, with three epitopes from gp100 and one from TRP-2 engineered into its CDR regions...
article
Issue #6 2015 – Digital edition
In digital version of Issue #6 2015: Microbiology, Screening, PCR, Continuous Manufacturing, PAT, Regulation, and much more...
article
MIQE compliance in expression profiling and clinical biomarker discovery
6 January 2016 | By Irmgard Riedmaier, Melanie Spornraft, Benedikt Kirchner and Michael W. Pfaffl, Technical University of Munich
Molecular diagnostics and biomarker discovery are gaining increasing attraction in clinical research. This includes all fields of diagnostics, such as risk assessment, disease prognosis, treatment prediction and drug application success control. The detection of molecular clinical biomarkers is very widespread and can be developed on various molecular levels, like the…
news
Existing drugs show promise as antibiotic agents
4 January 2016 | By Victoria White
University of Illinois researchers have found that a number of existing drugs approved for the treatment of various conditions, such as cancer or infertility, show promise as antibiotic agents...
news
EUCAST researches new critical breakpoints for antimicrobial agents
7 December 2015 | By Victoria White
Breakpoints of new agents are absolutely vital in standardising a global definition of resistance and the point at which increased dosages are needed...
news
ECDC survey shows increasing threat of antibiotic resistance
18 November 2015 | By Victoria White
Survey results released by the ECDC show that the situation continues to worsen with regard to the spread of CPE in the EU, with 3 countries reporting an endemic situation...
news
ESCMID highlights projects in the fight against antimicrobial resistance
13 November 2015 | By Victoria White
Ahead of the European Antibiotic Awareness Day, ESCMID has highlighted two of its more recent projects in the fight against antimicrobial resistance...
news
Research reveals antibiotic prescriptions are rising in the most deprived areas
12 November 2015 | By Victoria White
The data reveals antibiotic prescribing hotspots and interesting correlations against areas of deprivation. It also shows seasonal variation in antibiotic prescribing...
news
Coulter Partners recruits two to Curetis NV Supervisory Board
3 November 2015 | By Coulter Partners
Coulter Partners was delighted to partner with German diagnostics company Curetis AG on two strategic supervisory board appointments and congratulates them on their recent IPO launch...
article
Issue #5 2015 – Digital edition
In Issue #5 2015: Counterfeit Drugs, Regulatory Insight, Raman In-Depth Focus, PAT Series, Polymorphs, RMM In-Depth Focus, Particle Sizing, Freeze Drying, and much more...
news
Novartis expands its cancer immunotherapy portfolio
21 October 2015 | By Victoria White
Novartis is broadening its portfolio of cancer immunotherapies through the acquisition of Admune Therapeutics and licensing agreements with Palobiofarma and XOMA Corporation...
webinar
Development of biosensor assays for fragment screening of wild type GPCRs
14 October 2015 | By GE Healthcare
In this webinar, we discuss SPR fragment screening of wild type GPCRs enabled by sensitive biosensors and optimised membrane protein assays...
